Healthcare / Medical Care FacilitiesThailand
$7.50
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $903.2M · quality 81.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
52/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$15.2B
P/E
22.7x
↑EV/EBITDA
9.6x
↓ROE
9.6%
↑Gross Margin
30.1%
↓Debt/Equity
0.08
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+2.1%
FCF CAGR
+6.9%
FCF margin
18.5%
FCF / Net income
1.49x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $6.05B · net income $751.8M · FCF $1.12B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $6.05B | $6.05B | $6.06B | $5.82B | $5.67B |
| Net Income | $751.8M | $751.8M | $663.6M | $891.1M | $1.01B |
| EBITDA | $1.58B | $1.58B | $1.43B | $1.66B | $1.78B |
| EPS | 0.37 | 0.37 | 0.32 | 0.43 | 0.49 |
| Gross Margin | 30.1% | 30.1% | 29.1% | 34.4% | 35.9% |
| Operating Margin | 15.5% | 15.5% | 13.8% | 19.4% | 22.7% |
| Net Margin | 12.4% | 12.4% | 11.0% | 15.3% | 17.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.08 | 0.08 | 0.11 | 0.10 | 0.14 |
| Current Ratio | 3.49 | 3.49 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.12B | $1.12B | $903.2M | $578.6M | $914.4M |
| Returns | |||||
| ROE | 9.6% | 9.6% | 8.7% | 12.1% | 14.8% |
| Valuation | |||||
| P/E | 22.73 | 22.73 | 29.43 | 24.19 | 28.06 |
| EV/EBITDA | 9.59 | 9.59 | 13.69 | 13.14 | 15.93 |
| P/B | 1.96 | 1.96 | 2.53 | 2.91 | 4.15 |
| Growth & Yield | |||||
| Revenue Growth | -0.2% | -0.2% | 4.1% | 2.6% | — |
| EPS Growth | 15.6% | 15.6% | -25.6% | -12.2% | — |
| Dividend Yield | 3.6% | 3.6% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
21.6%
EPS terminal req.
$0.67
Spread vs growth
-6.0%
5Y implied EPS CAGR
16.8%
EPS terminal req.
$0.81
Spread vs growth
-1.2%
10Y implied EPS CAGR
13.4%
EPS terminal req.
$1.30
Spread vs growth
2.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-6.9%
Start / end P/E
24.4x → 18.9x
EPS bridge
0.32 → 0.37
Residual
-3.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.